TP73 and cancer: TP73-AS1 was demonstrated to promote MB growth in vitro and in vivo and to modulate the expression of the eukaryotic translation initiation factor EIF5A2, an oncogene upregulated in several cancers including MB (Yang et al., 2019) by sponging miR-494-3p, previously reported as a putative oncogenic miRNA (Lin et al., 2018).